baber/WOPTO huggingface dataset:
Patent EP-4107601-A1 (EP)
Inventor: VOSS-WOLFF CHRISTIAN
IPC: G02B27/01
Filed: 2021-01-04
Abstract: Example image reprojection methods are disclosed. In one example, a depth buffer of depth values corresponding to an image produced based on a predicted pose is divided into a plurality of tiles. For each tile of the plurality of tiles, a planar deviation error value that estimates a geometric complexity of the tile and penalizes the tile in proportion to an extent to which a geometry of the tile deviates from a plane is calculated. A tessellated mesh of the plurality of tiles is produced based on the planar deviation error values calculated for the plurality of tiles. An updated pose is received. The tessellated mesh is rendered based on the updated pose to output a reprojected image.
Patent EP-4297564-A1 (EP)
Inventor: LIGTHART JOHANNES THEODORUS WILHELMUS
IPC: A01H1/00
Filed: 2021-02-24
Abstract: La présente invention concerne des plantes de  Brassica oleracea  résistantes à  Albugo Candida  pathogène de plantes et la résistance étant codée par une région génomique sur le chromosome 2. La présente invention concerne en outre des procédés d'identification de la présente résistance à  Albugo Candida  et des marqueurs moléculaires destinés à être utilisés dans les présents procédés.
Patent EP-4099821-A1 (EP)
Inventor: Kajimura Daisuke
IPC: A01K67/027
Filed: 2021-02-05
Abstract: Non-human animal genomes, non-human animal cells, and non-human animals comprising a humanized KLKB1 locus and methods of making and using such non-human animal genomes, non-human animal cells, and non-human animals are provided. Non-human animal cells or non-human animals comprising a humanized KLKB1 locus express a human plasma kallikrein protein or a chimeric plasma kallikrein protein, fragments of which are from human plasma kallikrein. Methods are provided for using such non-human animals comprising a humanized KLKB1 locus to assess in vivo efficacy of human-KLKB 1 -targeting reagents such as nuclease agents designed to target human KLKB1.
Patent EP-4114231-A1 (EP)
Inventor: KALS KARL
IPC: A47B87/02
Filed: 2021-02-25
Abstract: Erfindungsgemäß ist ein Verbindungselement (1) vorgesehen, umfassend eine Basisplatte (2), welche mit zumindest einem ersten Aufnahmeelement (3) und einem zweiten Aufnahmeelement (4) verbunden ist, wobei das erste Aufnahmeelement (3) und das zweite Aufnahmeelement (4) jeweils eine erste Leiste (7) und eine zweite Leiste (8) aufweisen, die zur Basisplatte (2) jeweils im Wesentlichen senkrecht angeordnet sind, wobei die erste und die zweite Leiste (7,8) des ersten Aufnahmeelements (3) und die Basisplatte (2) eine erste Aufnahmenut (9) begrenzen, die zur Aufnahme eines Trennelements (23) ausgebildet ist, und die erste und die zweite Leiste (7, 8) des zweiten Aufnahmeelements (4) und die Basisplatte (2) eine zweite Aufnahmenut (10) begrenzen, die zur Aufnahme eines Trennelements (23) ausgebildet ist.
Patent EP-4107284-A1 (EP)
Title: In situ analysis of chromatin interaction
Inventor: STAHL PATRIK
IPC: C12Q1/6841
Filed: 2021-02-17
Abstract: In some embodiments described herein are methods performed in situ for analyzing chromatin interaction events in a cell or in cells of a sample such as a non-homogenized tissue sample. The methods can comprise the spatial analysis of chromatin interaction events across cell populations in a biological sample. The methods can further comprise obtaining a biological sample, hybridizing probes to target nucleic acid sequences involved in chromatin interaction events and producing a nucleic acid sequence comprising all or part of the target nucleic acid sequences, amplifying the nucleic acid sequence so produced and detecting the amplified nucleic acid sequence  in situ .
Patent EP-4121279-A1 (EP)
Inventor: ZHENG YANG
IPC: G02C7/04
Filed: 2021-03-18
Abstract: The invention is generally related to a method for producing, in a relatively efficient and consistent manner, embedded or hybrid silicone hydrogel contact lenses, and also to unprocessed embedded or hybrid silicone hydrogel contact lenses, according to conventional cast-molding technologies. A method of the invention involve use of a polymeric non-reactive diluent in preparing a polymerizable composition for forming the silicone hydrogel material of the unprocessed embedded or hybrid silicone hydrogel contact lens, which is cast-molded with a lens mold. The unprocessed cast-molded embedded or hybrid silicone hydrogel contact lens has no or a minimal water-swelling degree, so that lens distortion or delamination during the hydration of the unprocessed embedded or hybrid silicone hydrogel contact lens.
Patent EP-4127371-A1 (EP)
Inventor: ORJEBIN PIERRE
IPC: E06B3/66
Filed: 2021-04-01
Abstract: Said facade module (18), designed to separate an interior area (14) from an exterior area (16) of a building space (17), comprises: - a partition plate (24), comprising an inner face (28) and an outer face (30), the partition plate comprising an inner glazed layer (32) forming the inner face (28), and - an attachment member (26) of the partition plate (24) designed to attach the partition plate (24) to a building structure (20). The partition plate (24) comprises at least one rock layer (38) forming the outer face (30) of the partition plate (24) and/or extending over the inner glazed layer (32).
Patent EP-4127180-A1 (EP)
Title: Forskolin-inducible promoters and hypoxia-inducible promoters
Inventor: WHYTESIDE GRAHAM
IPC: C12N15/63
Filed: 2021-03-26
Abstract: The present invention relates to forskolin-inducible and hypoxia-inducible cis-regulatory elements, promoters and vectors, and methods of their use.
Patent EP-4125696-A1 (EP)
Inventor: FITTIPALDI MAURO
IPC: A61B90/00
Filed: 2021-03-30
Abstract: A splint device for robotically-guided surgery includes elongate co-extending first and second splint portions each defining spaced-apart relief holes between first and second ends. A first separability provision is disposed between and extends along the first and second splint portions. A tracking portion is engaged with and extends outwardly from the first or second splint portion and extending outwardly therefrom, and has a kinematic mount engaged therewith. A second separability provision extending between one of the relief holes of the first splint portion and one of the relief holes of the second splint portion, wherein the second separability provision is arranged to be severable so as to facilitate adjustability of a length of the first and second splint portions and the first separability provision. The splint device can include a tool calibration provision or a fiducial marker element disposed in a predetermined disposition relative to the kinematic mount.
Patent EP-4121424-A1 (EP)
Inventor: FLEMING PAUL E
IPC: A61P35/00
Filed: 2021-03-19
Abstract: The present invention provides, in part, novel small molecule inhibitors of PHD, having a structure according to Formula (A), and sub-formulas thereof: or a pharmaceutically acceptable salt thereof. The compounds provided herein can be useful for treatment of diseases including heart (e.g. ischemic heart disease, congestive heart failure, and valvular heart disease), lung (e.g., acute lung injury, pulmonary hypertension, pulmonary fibrosis, and chronic obstructive pulmonary disease), liver (e.g. acute liver failure and liver fibrosis and cirrhosis), and kidney (e.g. acute kidney injury and chronic kidney disease) disease.
Patent EP-4139950-A1 (EP)
Title: P+ or n+ type doping process for semiconductors
Inventor: MAGGIONI GIANLUIGI
IPC: H01L21/225
Filed: 2021-04-20
Abstract: A p+ or n+ type doping process for semiconductors, allows to implement a semiconductor with a highly doped surface layer, and it comprises the steps of: providing a substrate made of semiconductor material; depositing on a surface of 5 the substrate made of semiconductor material a thin source layer made of dopant material acting as dopant source; depositing on said source layer an additional protective surface layer made of semiconductor material; inducing liquefaction of the surface layer at least until the source layer; and cooling down the substrate surface so as to obtain the diffusion of the dopant material.
Patent EP-4139008-A1 (EP)
Inventor: PETERSEN STEEN VEJEN
IPC: A63B71/06
Filed: 2021-04-19
Abstract: Procédé de fonctionnement d'un système d'exercice d'amélioration de la motivation. Le système d'exercice comprend un dispositif d'exercice conçu pour être entraîné par un utilisateur faisant l'exercice, un dispositif de sortie monté sur la tête conçu pour délivrer une sortie visuelle et/ou sonore pour un utilisateur faisant l'exercice, et une unité de traitement. Les mouvements d'une partie mobile du dispositif d'exercice sont mesurés à l'aide d'une première unité de capteur montée sur la partie mobile, et les mouvements d'une tête de l'utilisateur sont mesurés à l'aide d'une seconde unité de capteur comprise dans le dispositif de sortie monté sur la tête. L'unité de traitement détermine une activité qui est réalisée par l'utilisateur faisant l'exercice, sur la base des mesures fournies depuis la première unité de capteur et la seconde unité de capteur, et génère un signal de sortie pour le dispositif de sortie monté sur la tête, en fonction de l'activité déterminée. Le dispositif de sortie monté sur la tête fournit une sortie visuelle et/ou sonore pour l'utilisateur faisant l'exercice en fonction du signal de sortie.
Patent EP-4127884-A1 (EP)
Inventor: FERRANTE SIMONA
IPC: G06F3/0354
Filed: 2021-03-30
Abstract: The present invention relates to a writing instrument (1) comprising: - a writing element (20) comprises a writing end (21) configured for depositing a writing material on a support; - a plurality of sensors comprising at least: - a force sensor (30) configured to measure a force applied to said writing element (20), and - a movement sensor (43) configured to measure movement of the instrument (1) in a three- dimensional space; - a communication unit (44) configured to exchange data with a remote device via a wireless communication channel; - a control unit (41) connected to the plurality of sensors and to the communication unit (44) configured to control said plurality of sensors and said communication unit (44) in order to transmit to the remote device the measures provided of the plurality of sensors in presence of a connection between the communication unit (44) and the remote device, - a memory unit (42) connected to the control unit (41) and configured to store one or more measures of said plurality of sensors, and - a hollow casing (10) configured to contain at least partially said writing element (20), so as to leave the writing end (21) of the writing element (20) exposed through a first end (11) of the casing (10), and to contain completely said plurality of sensors, the control unit (41), the memory unit (42) and the communication unit (44). Advantageously, the control unit is further configured: - to detect a condition of lack of connection between the communication unit (44) and the remote device, - in such a condition of lack of connection, to detect writing measures corresponding to movement measures having amplitude of movement greater than a threshold, and - to store the writing measures if, within a predetermined period of time, the control unit detects a number of writing measures greater than a predetermined number.
Patent EP-4146016-A1 (EP)
Title: Compositions et méthodes pour des articulations saines
Inventor: RANA JATINDER
IPC: A23L33/11
Filed: 2021-04-12
Abstract: L'invention concerne des compositions et des méthodes de maintien de la structure osseuse, de la structure cartilagineuse ou les deux, réduisant au minimum la réabsorption du pavillon, prévenant la dégradation des cartilages, augmentant la densité osseuse, promouvant des articulations saines en protégeant l'intégrité des cartilages, diminuant l'action d'enzymes qui affectent la santé osseuse, la santé cartilagineuse, ou les deux, améliorant le mouvement ou la fonction des articulations, soulageant les douleurs articulaires, soulageant l'inconfort articulaire, soulageant les douleurs et l'inconfort articulaires, soulageant la raideur articulaire, améliorant la plage de mouvement ou la flexibilité des articulations, favorisant la mobilité, ou similaire, la composition comprenant une quantité thérapeutiquement efficace d'un extrait botanique du testa de  Anacardium occidentale L , l'extrait botanique étant enrichi pour obtenir une teneur totale en catéchine.
Patent EP-4138640-A1 (EP)
Inventor: GILL CHRISTOPHER ANDREW WAKELEY
IPC: G16H50/30
Filed: 2021-04-20
Abstract: A method includes receiving first data associated with a first sleep session of a user (601). The method also includes determining a first set of sleep-related parameters associated with the first sleep session of the user based at least in part on the first data (602). The method also includes receiving second data associated with a second sleep session of the user (605). The method also includes determining a second set of sleep-related parameters associated with the second sleep session of the user based at least in part on the second data (606). The method also includes causing one or more indications associated with the variable condition and the first sleep session, the second sleep session, or both to be communicated to the user (604, 609).
Patent EP-4143371-A1 (EP)
Inventor: EBNER ROBERT
IPC: C30B11/00
Filed: 2021-04-27
Abstract: The present invention relates to a crucible device (100) for growing crystals. The crucible device (100) comprises a heating chamber (140), at least a first crucible (110) in which a first crystal (111) is growable, and at least a second crucible (120) in which a second crystal (121) is growable. The first crucible (110) and the second crucible (120) are arranged within the heating chamber (140) spaced apart from each other along a horizontal and vertical and any orientational direction. The crucible device (100) further comprises a heating system arranged within the heating chamber (140), wherein the heating system is configured for adjusting a temperature along the horizontal and vertical and any orientational directions.
Patent EP-4140162-A1 (EP)
Inventor: PALADUGU KARTHIKA
IPC: H04W88/04
Filed: 2021-04-22
Abstract: La présente invention concerne, selon divers aspects, des procédés de sécurisation d'une liaison de communication poste à poste qui sert à relayer des transmissions vers/depuis un nœud de réseau mobile géré. Un premier équipement utilisateur peut identifier un second équipement utilisateur qui peut communiquer par l'intermédiaire d'une interface sans fil poste à poste et servir de relais entre le premier équipement utilisateur et un nœud de réseau mobile géré. Un matériel clé de la session de relais peut être obtenu du nœud de réseau mobile géré. Une liaison de communication poste à poste entre le premier équipement utilisateur et le second équipement utilisateur peut être établie ou modifiée à l'aide, par exemple, de la sécurisation de la liaison de communication poste à poste sur la base du matériel clé de la session de relais. Une session d'unité de données de protocole peut être établie, sur la liaison de communication poste à poste, entre le premier équipement utilisateur et le nœud de réseau mobile géré pour des transmissions sécurisées entre eux.
Patent EP-4146148-A1 (EP)
Title: Oral care compositions comprising dicarboxylic acid
Inventor: CURTIS MICHAEL DAVID
IPC: A61K8/362
Filed: 2021-05-05
Abstract: Oral care compositions including dicarboxylic acid and a pH of from about 4 to about 6. Oral care kits including a first oral care composition with fluoride and a second oral care composition with dicarboxylic acid. Oral care compositions including fluoride and dicarboxylic acid that provide an erosion benefit, a stain prevention benefit, and/or a stain removal benefit.
Patent EP-4226127-A1 (EP)
Inventor: MACK TOBIAS
IPC: G01F15/06
Filed: 2021-06-02
Abstract: A metering console (100) includes a housing (110) adapted to allow flow of a liquid (F) therethrough. The housing (110) is adapted to attach with one or more gardening devices (132, 152). The metering console (100) includes a display (170) associated with the housing (110). The metering console (100) is characterized in that the display (170) is rotatably engaged with the housing (110) of the metering console (100) such that the display (170) rotates along a central axis (A -A') of the housing (110).
Patent EP-4173263-A1 (EP)
Inventor: BARAC FILIP
IPC: H04L45/24
Filed: 2021-06-02
Abstract: Embodiments include methods for a user equipment (UE) to perform quality of experience (QoE) measurements configured by a wireless network. Such methods include receiving, from a radio access network node (RNN) in the wireless network, a QoE measurement configuration for one or more services provided by the UE application layer. Such methods include performing application-layer QoE measurements for the one or more services according to the QoE measurement configuration and sending, to or via the RNN in accordance with QoE measurement configuration, one or more messages comprising: one or more QoE measurement reports comprising results of the QoE measurements; and network assistance information (NAI) related to one or more paths that carry data associated with the one or more services. Other embodiments include complementary methods for RNNs and measurement functions, as well as UEs, RNNs, and measurement functions configured to perform such methods.
Patent EP-4153147-A1 (EP)
Inventor: ROSA ANTHONY
IPC: A61K38/00
Filed: 2021-05-19
Abstract: L'invention concerne un procédé d'encapsulation d'un composé biologique hydrophile ou amphiphile, des particules obtenues par ledit procédé, des compositions les comprenant et leurs utilisations.
Patent EP-4176688-A1 (EP)
Inventor: BARAC FILIP
IPC: H04W24/10
Filed: 2021-06-29
Abstract: Systems and methods are disclosed that relate to Quality of Experience (QoE) measurement reporting in a cellular communications system having a split, or distributed, Radio Access Network (RAN) architecture. In one embodiment, a method performed in a RAN having a distributed RAN architecture comprises, at a control plane part of a central unit (CU-CP) of a base station of the RAN, sending one or more first messages to a user plane part of the central unit (CU-UP) to setup or modify one or more bearers and sending one or more second message to a distributed unit (DU) of the base station to setup or modify the one or more bearers.
Patent EP-4222603-A1 (EP)
Inventor: LIN JIN
IPC: G06F11/36
Filed: 2021-06-14
Abstract: A verified stack trace can be generated by utilizing information contained in a shadow stack, such as a hardware protected duplicate stack implemented for malware prevention and computer security. The shadow stack contains return addresses which are obtainable without requiring an unwinding of the traditional call stack. As such, triaging based on return address information can be performed more quickly and more efficiently, and with a reduced utilization of processing resources. Additionally, the generation of a verified stack trace can be performed, with such a verified stack trace containing return addresses that are known to be correct and not corrupted. The return addresses can either be read from the traditional call stack, or derived therefrom, and then verified by comparison to corresponding return addresses from the shadow stack, or they can be read directly from the shadow stack.
Patent EP-4168068-A1 (EP)
Title: Atomic layer deposition coated pharmaceutical packaging and improved syringes and vials, e.g. for lyophilized/cold-chain drugs/vaccines
Inventor: TAHA AHMAD
IPC: A61M5/31
Filed: 2021-06-22
Abstract: The present disclosure is directed to pharmaceutical packaging such as syringes, vials, and blood tubes having a thermoplastic wall that is coated with a gas barrier coating in which at least one layer is applied by atomic layer deposition. The gas barrier coating may include, for example, one or more layers of SiO 2 , one or more layers of Al2O3, or a combination thereof, and may serve as a barrier against a variety of gases including oxygen, water vapor, and nitrogen. The present disclosure is also directed to syringes and vials which are configured for the storage of lyophilized or cold-chain drugs and in particular to maintain container closure integrity throughout the supply and storage conditions associated with such drugs. The present disclosure is also directed to evacuated blood tubes having extended shelf lives.
Patent EP-4093307-A1 (EP)
Inventor: FISCHMANN FERNANDO BENJAMIN
IPC: A61B18/04
Filed: 2021-01-21
Abstract: The invention provides an innovative low cost, efficient, short duration, and painless minimally invasive device and method for tightening sagging skin through linear tensing and stimulation of collagen production. More particularly still, the device and method not only allow applying heat directly in the dermis layer of the skin, but also allows for administering an anesthetic and optionally additional ant-inflammatory or collagen induction fluids through the same apparatus.
Patent EP-4188325-A1 (EP)
Inventor: HAMMOND KEVIN
IPC: A61K47/34
Filed: 2021-07-27
Abstract: The present invention is directed to a topical formulation comprising 1) a dispersed phase comprising: 5 to 15% w/w (percentage weight/weight) nicotinamide; 10 to 60% w/w of a partition coefficient enhancer (Pc enhancer), having a structure of the general formula: C n H 2n+2 O 2  where n represents an integer from 3 to 6 inclusive; and ≤ 10% water and 2) a continuous phase, wherein the formulation has a pH above 4.0. The present invention is also directed to a pharmaceutical composition comprising the topical formulation according to the invention, a pharmaceutical composition according to the invention for use in therapy, and the use of the topical formulation as a cosmetic agent.
Patent EP-4109149-A1 (EP)
Title: Patterned film, variable-transmittance device comprising same, and method for producing variable-transmittance device
Inventor: SONG CHEOLOCK
IPC: G02F1/1335
Filed: 2021-02-04
Abstract: The present specification relates to a pattern film, a transmittance variable device comprising the same, and a method for manufacturing a transmittance variable device.
Patent EP-4113205-A1 (EP)
Inventor: FENG BO
IPC: G02F1/1362
Filed: 2021-02-02
Abstract: Provided is an array substrate (100) and a display device, and belongs to the field of display technologies. The array substrate (100) includes: a base substrate (10), and a plurality of gate lines (20), a plurality of data lines (30), a plurality of sub-pixels (40) and a plurality of touch signal lines (50) disposed on the base substrate (10). The data lines (30) have a plurality of first extending parts (301) and a plurality of second extending parts (302) which are in an alternating arrangement. When the array substrate (100) is used to prepare a liquid crystal display panel and the liquid crystal display panel is displaying, in each column of the sub-pixels (40), the voltage polarities of the two sub-pixels (40) which respectively belong to two adjacent first pixel regions are opposite. The voltage polarities of the same type of sub-pixels (40) in the same frame of image can be effectively averaged on a space dimension, thereby reducing the probability of the occurrence of the Vertical lines, and effectively improving the display effect of the liquid crystal display panel.
Patent EP-4110932-A1 (EP)
Title: Treating autosomal recessive bestrophinopathies and methods for evaluating same
Inventor: GUZIEWICZ KARINA E
IPC: C12N15/87
Filed: 2021-02-28
Abstract: Methods for treating bestrophinopathies are provided herein. The method includes, administering to an eye of the subject a dose of a recombinant adeno-associated virus (rAAV) vector comprising a nucleic acid sequence encoding a human BEST1 protein, wherein the subject has two mutant BEST1 alleles. Also provided are methods for evaluating treatments for retinal degeneration.